Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
84.60    0.60 (0.71%)
Bid:
82.20
Ask:
84.60
Spread: 2.40 (2.92%)
Market Cap: £55.65m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Directors' Shareholdings

20 Mar 2018 16:57

RNS Number : 3495I
Robert Walters PLC
20 March 2018
Β 

20 March 2018

ROBERT WALTERS PLC

(the "Company")

Directors' Shareholdings

The Company was informed on 20 March 2018 of the following dealings by the Executive Directors in Ordinary Shares.

Director

Number of PSP shares sold

Sale price (p)

Robert Walters

137,320

650

Giles Daubeney

114,489

650

Alan Bannatyne

83,842

650

Total

335,651

Β 

These dealings were pursuant to the vesting of awards under the Robert Walters Long Term Incentive Plan ("LTIP") on 1 March 2018. Pursuant to instructions given by each of the Executive Directors, a fixed proportion of the awards were exercised and sold on 20 March 2018 to satisfy the associated tax obligations arising upon the exercise of the Ordinary Shares.

Β 

As a result of the subsequent share sales, there has therefore been a change in the overall shareholdings of each of the Executive Directors as set out below:

Director

Shareholding prior to this announcement

% holding in Company

Shareholding after this announcement

% holding in Company

Robert Walters

2,553,151

3.39

2,415,831

3.20

Giles Daubeney

1,907,711

2.53

1,793,222

2.38

Alan Bannatyne

686,655

0.91

602,813

0.80

Β 

Robert Walters plc's issued share capital now consists of 79,493,900 Ordinary Shares with voting rights. Robert Walters plc holds 4,074,000 Ordinary Shares in Treasury.

Therefore, the total number of voting rights in Robert Walters plc is 75,419,900.

The above figure of 75,419,900 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Robert Walters plc under the FSA's Disclosure and Transparency Rules.

Β 

Further information

Robert Walters plc

Robert Walters, Chief Executive

Alan Bannatyne, Chief Financial Officer

Β 

+44 20 7379 3333

Newgate Communications

Steffan Williams

Charlotte Coulson

+44 20 7680 6550

Β 

Β 

www.robertwalters.com

Β 

Β 

Β 

APPENDIX

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Robert Walters

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Sale of Ordinary Shares under the Robert Walters plc Long Term Incentive Plan.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

650p

137,320

(e)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

137,320 (LTIP)

650p

(f)

Date of the transaction

20 March 2018

(g)

Place of the transaction

London Stock Exchange

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Giles Daubeney

2.

Reason for the notification

(a)

Position/status

Deputy Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Sale of Ordinary Shares under the Robert Walters plc Long Term Incentive Plan.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

650p

114,489

(e)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

114,489 (LTIP)

650p

(f)

Date of the transaction

20 March 2018

(g)

Place of the transaction

London Stock Exchange

Β 

Β 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Alan Bannatyne

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Robert Walters plc

(b)

LEI

213800LIE15BDEN3VW43

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of 20p each

(b)

Identification code of the Financial Instrument

ISIN Code : GB0008475088

(c)

Nature of the transaction

Sale of Ordinary Shares under the Robert Walters plc Long Term Incentive Plan.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

650p

83,842

(e)

Aggregated information

- Aggregated volume

- Price

Β 

Β 

83,842 (LTIP)

650p

(f)

Date of the transaction

20 March 2018

(g)

Place of the transaction

London Stock Exchange

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHFKKDPABKDPNB
Date   Source Headline
14th May 20269:24 amRNSDirector/PDMR Shareholding
13th May 202610:40 amRNSDirector/PDMR Shareholding
5th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSDirector/PDMR Shareholding
30th Apr 20263:16 pmRNSResult of AGM
30th Apr 202610:27 amRNSDirectorate change
28th Apr 202610:10 amRNSDirector/PDMR Shareholding
24th Apr 20269:34 amRNSDirector/PDMR Shareholding
17th Apr 20269:03 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSQ1 2026 Trading Update
14th Apr 20265:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Apr 20263:46 pmRNSHolding(s) in Company
1st Apr 20266:12 pmRNSAnnual Financial Report
30th Mar 20267:00 amRNSBoard and Management Changes
27th Mar 20262:56 pmRNSHolding(s) in Company
27th Mar 20262:54 pmRNSHolding(s) in Company
23rd Mar 20269:21 amRNSHolding(s) in Company
17th Mar 202610:00 amRNSHolding(s) in Company
11th Mar 20267:00 amRNS2025 Full-Year Results
3rd Feb 20264:08 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
18th Nov 20255:10 pmRNSHolding(s) in Company
17th Nov 20255:00 pmRNSHolding(s) in Company
6th Nov 20258:55 amRNSBLOCK LISTING SIX-MONTHLY RETURN
14th Oct 20257:00 amRNSQ3 2025 Trading Update
11th Sep 20253:06 pmRNSHolding(s) in Company
8th Aug 20252:33 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20254:56 pmRNSHolding(s) in Company
23rd Jul 20254:54 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSQ2 2025 Trading Update
9th Jun 20252:11 pmRNSHolding(s) in Company
4th Jun 20253:49 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSHolding(s) in Company
30th Apr 20254:09 pmRNSHolding(s) in Company
29th Apr 20252:59 pmRNSResult of 2025 Annual General Meeting
16th Apr 202512:06 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ1 2025 Trading Update
28th Mar 202511:00 amRNSAnnual Report and Annual General Meeting
12th Mar 202511:47 amRNSDirector/PDMR Shareholding
7th Mar 20259:28 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 full-year results
14th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSQ4 2024 Trading Update
10th Jan 20254:22 pmRNSHolding(s) in Company
17th Dec 20244:32 pmRNSHolding(s) in Company
13th Dec 202411:06 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.